Glenmark Pharmaceuticals close over 1% higher, trims most of early gains
Glenmark stocks closed 1.16 per cent higher at Rs 480.90 on BSE.
Aug 17, 2020, 17:47 PM IST
Glenmark Pharmaceuticals' Q1 net profit up 24% at Rs 227 cr
Glenmark Pharmaceuticals on Friday reported a 23.96 percent rise in consolidated net profit to Rs 226.78 crore for the first quarter ended June 30, 2016, mainly on account of robust sales.
Aug 12, 2016, 15:27 PM IST
Glenmark gets two ANDA approvals from USFDA
Glenmark Pharmaceuticals has received final approval from the US health regulator USFDA for oral contraceptives and leukemia treatment injection.
Mar 28, 2016, 16:15 PM IST
Glenmark seeks shareholders' nod to raise up to $500 million
Glenmark Pharmaceuticals seeks shareholders' approval to raise up to USD 500 million (around Rs 3,300 crore) by issue of securities to fund its expansion plans, including setting up of new manufacturing facilities.
Dec 24, 2015, 17:22 PM IST
Glenmark gets USFDA final nod for anti-bacterial drug
Glenmark Pharmaceuticals has received the final nod from the US health regulator for a generic version of anti-bacterial drug Zyvox.
Dec 22, 2015, 13:02 PM IST
Corporate Earnings: Top gainers and losers in Q2 results announced today
The major gainers and losers announcing corporate earnings on Friday:
Oct 30, 2015, 16:07 PM IST
Glenmark Pharma scrip gains 6% post Q2 earnings
Shares of Glenmark Pharmaceuticals today climbed 6 per cent after the company reported 20 per cent increase in consolidated net profit for the second quarter ended September 30.
Oct 30, 2015, 13:31 PM IST
Glenmark Q2 net up 20% at Rs 198 crore
Glenmark Pharmaceuticals Thursday reported 19.81 percent increase in consolidated net profit to Rs 197.78 crore for the second quarter ended September 30, driven by good growth in India, US and Europe.
Oct 29, 2015, 22:19 PM IST
Glenmark evaluating legal options over diabetes drugs setback
Drug firm Glenmark Pharmaceuticals today said it is evaluating legal options after the Delhi High Court restrained it from manufacturing and selling generic version of MSD's anti-diabetes medicines Januvia and Janumet.
Oct 08, 2015, 21:32 PM IST
Blow to Glenmark: HC restrains it from making anti-diabetes drugs
In a blow to Indian drug firm Glenmark Pharmaceuticals, Delhi High Court Wednesday restrained it from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met on the ground that it violated the patent of US pharma major Merck Sharp and Dohme (MSD).
Oct 07, 2015, 22:26 PM IST
Glenmark Pharma eyes US biz to be strong growth driver
Glenmark Pharmaceuticals Tuesday said it is looking at strong growth in the US market and developing a pipeline of innovative products to offset weakness in emerging markets.
Sep 22, 2015, 21:39 PM IST
India drugmaker stocks exception in Asian rout
In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.
Sep 03, 2015, 19:37 PM IST
Glenmark receives USFDA nod for oral contraceptive drug
"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg," the company said in a BSE filing.
Aug 19, 2015, 11:47 AM IST
Glenmark Q1 net up 3.29% at Rs 191 crore
Glenmark Pharmaceuticals on Thursday posted 3.29 percent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets.
Jul 30, 2015, 18:27 PM IST
Glenmark gets USFDA final nod for contraceptive tablets
Glenmark Pharmaceuticals has received final nod from the US health regulator for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.
Jun 15, 2015, 15:44 PM IST
Glenmark gets final USFDA nod for psoriasis cream
Glenmark Pharma was today trading at Rs 867.35 in the afternoon trade on BSE, up 1.19 percent.
Jun 11, 2015, 14:20 PM IST
Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr
Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.
May 19, 2015, 21:29 PM IST
FIIs can now invest up to 49% in Glenmark Pharma
The Reserve Bank Tuesday allowed foreign institutional investors (FIIs) to buy up to 49 percent stake in homegrown drug major Glenmark Pharmaceuticals.
May 19, 2015, 21:26 PM IST
Supreme Court bars Glenmark from selling Merck drug copies
Glenmark is barred from producing sitagliptin until the next hearing on the case, the order said.
May 15, 2015, 20:32 PM IST
Glenmark gets tentative USFDA nod for generic psoriasis cream
The product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of the same strength.
May 04, 2015, 13:32 PM IST
